1P6B image
Deposition Date 2003-04-29
Release Date 2003-09-16
Last Version Date 2023-11-15
Entry Detail
PDB ID:
1P6B
Keywords:
Title:
X-ray structure of phosphotriesterase, triple mutant H254G/H257W/L303T
Biological Source:
Source Organism:
Host Organism:
Method Details:
Experimental Method:
Resolution:
1.90 Å
R-Value Free:
0.23
R-Value Work:
0.17
R-Value Observed:
0.17
Space Group:
C 1 2 1
Macromolecular Entities
Polymer Type:polypeptide(L)
Molecule:Parathion hydrolase
Gene (Uniprot):opd
Mutations:H254G, H257W, L303T
Chain IDs:A, B
Chain Length:336
Number of Molecules:2
Biological Source:Flavobacterium sp.
Modified Residue
Compound ID Chain ID Parent Comp ID Details 2D Image
KCX A LYS LYSINE NZ-CARBOXYLIC ACID
Primary Citation
Enhanced degradation of chemical warfare agents through molecular engineering of the phosphotriesterase active site.
J.Am.Chem.Soc. 125 8990 8991 (2003)
PMID: 15369336 DOI: 10.1021/ja0358798

Abstact

The bacterial phosphotriesterase has been utilized as a template for the evolution of improved enzymes for the catalytic decomposition of organophosphate nerve agents. A combinatorial library of active site mutants was constructed by randomizing residues His-254, His-257, and Leu-303. The collection of mutant proteins was screened for the ability to hydrolyze a chromogenic analogue of the most toxic stereoisomer of the chemical warfare agent, soman. The mutant H254G/H257W/L303T catalyzed the hydrolysis of the target substrate nearly 3 orders of magnitude faster than the wild-type enzyme. The X-ray crystal structure was solved in the presence and absence of diisopropyl methyl phosphonate. The mutant enzyme was ligated to an additional divalent cation at the active site that was displaced upon the binding of the substrate analogue inhibitor. These studies demonstrate that substantial changes in substrate specificity can be achieved by relatively minor changes to the primary amino acid sequence.

Legend

Protein

Chemical

Disease

Primary Citation of related structures